Novozymes A/S (NVZMY) Stock Analysis & Winston Score
Novozymes is a Danish company that makes enzymes and microorganisms — tiny biological tools that help other industries do their work more efficiently. Its products are used in everyday things like laundry detergent, bread, biofuels, and animal feed. Novozymes is one of the largest enzyme producers in the world, supplying manufacturers across food, agriculture, and household products. The company sells its enzymes and biological solutions directly to industrial customers, earning revenue through product sales rather than subscriptions or ads. It operates globally, with customers in over 130 countries and most revenue coming from North America, Europe, and Asia. Novozymes holds a strong competitive position because developing new enzymes requires years of specialized research, making it hard for new competitors to enter. The key growth driver is demand for biological alternatives to traditional chemicals, particularly in agriculture and sustainable fuels, though slower adoption of these newer applications remains a meaningful risk to growth.
Winston Score: 55/100 — Good
A decent business — some strong pillars, some weaker.
- Quality: Good (17/30)
- Growth: Mixed (8/20)
- Cash Flow: Mixed (4/10)
- Stability: Exceptional (10/10)
- Valuation: Good (5/10)
- Ownership: Good (10/15)
Key Facts
Price: $64.82
Market Cap: $30.2B
Sector: Basic Materials
Industry: Chemicals - Specialty
Exchange: Other OTC


